97 related articles for article (PubMed ID: 29027250)
1. Revisiting the need for bone marrow examination in chronic myeloid leukemia.
Tefferi A; Hanson CA; Ketterling RP
Am J Hematol; 2018 Jan; 93(1):5-7. PubMed ID: 29027250
[No Abstract] [Full Text] [Related]
2. Chronic Myeloid Leukemia With Myelofibrosis-Like Features. Clues of Accelerated Phase?
Binotto G; Bertorelle R; Bonaldi L; Frison L; Vianello F; Pizzi M
Int J Surg Pathol; 2019 Oct; 27(7):771-772. PubMed ID: 30813806
[No Abstract] [Full Text] [Related]
3. [Detection of the Mbcr/abl translocation using FISH in bone marrow samples from patients diagnosed with CML and ALL].
Vargas MT; Fernández-Novoa MC; García-Creus MD; González-Ruano J
Sangre (Barc); 1996 Oct; 41(5):399-400. PubMed ID: 9026927
[No Abstract] [Full Text] [Related]
4. Marked discordance between cytogenetic/molecular and morphologic findings in a patient with chronic myeloid leukemia.
Rashidi A; Courville E
Blood Cells Mol Dis; 2017 Mar; 63():32-33. PubMed ID: 28110131
[No Abstract] [Full Text] [Related]
5. Gelatinous transformation of bone marrow in chronic myeloid leukemia during treatment with imatinib mesylate: a disease or a drug effect?
Ram R; Gafter-Gvili A; Okon E; Pazgal I; Shpilberg O; Raanani P
Acta Haematol; 2008; 119(2):104-7. PubMed ID: 18367829
[TBL] [Abstract][Full Text] [Related]
6. Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec). Bone marrow histopathology and correlation with genetic status.
Frater JL; Tallman MS; Variakojis D; Druker BJ; Resta D; Riley MB; Hrisinko MA; Peterson LC
Am J Clin Pathol; 2003 Jun; 119(6):833-41. PubMed ID: 12817431
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow necrosis complicating chronic myeloid leukaemia.
Macheta AT; Cinkotai KI; Love EM; Geary CG; Liu Yin JA
Clin Lab Haematol; 1991; 13(2):163-7. PubMed ID: 1934927
[TBL] [Abstract][Full Text] [Related]
8. Prolonged T1 relaxation of the hemopoietic bone marrow in patients with chronic leukemia.
Jensen KE; Sørensen PG; Thomsen C; Christoffersen P; Henriksen O; Karle H
Acta Radiol; 1990 Sep; 31(5):445-8. PubMed ID: 2261287
[TBL] [Abstract][Full Text] [Related]
9. Ph-positive and -negative myeloproliferative syndromes may co-exist.
Mauro MJ; Loriaux M; Deininger MW
Leukemia; 2004 Jul; 18(7):1305-7. PubMed ID: 15103389
[No Abstract] [Full Text] [Related]
10. Cytogenetic studies on bone-marrow in chronic myeloid leukaemia.
TOUGH IM; JACOBS PA; COURT BROWN WM; BAIKIE AG; WILLIAMSON ER
Lancet; 1963 Apr; 1(7286):844-6. PubMed ID: 13993817
[No Abstract] [Full Text] [Related]
11. [Diagnosis of chronic myeloproliferative diseases based on bone marrow biopsy].
Matolcsy A; Kónya T; Wéber E
Orv Hetil; 1992 Jun; 133(26):1617-20, 1625-6. PubMed ID: 1614699
[TBL] [Abstract][Full Text] [Related]
12. Chronic myelogenous leukemia in sickle cell/beta 0-thalassemia.
Sallam MM; Alsuliman AM; Alahmed HE; Alabdulaali MK
Indian J Pathol Microbiol; 2011; 54(3):597-8. PubMed ID: 21934232
[TBL] [Abstract][Full Text] [Related]
13. Sequestration of Philadelphia chromosome-positive cells in the bone marrow of a chronic myeloid leukemia patient in very prolonged remission.
Birnie GD; MacKenzie ED; Goyns MH; Pollock A
Leukemia; 1990 Jun; 4(6):452-4. PubMed ID: 2359346
[No Abstract] [Full Text] [Related]
14. Comparison of bone marrow high mitotic index metaphase fluorescence in situ hybridization to peripheral blood and bone marrow real time quantitative polymerase chain reaction on the International Scale for detecting residual disease in chronic myeloid leukemia.
Lundán T; Juvonen V; Mueller MC; Mustjoki S; Lakkala T; Kairisto V; Hochhaus A; Knuutila S; Porkka K
Haematologica; 2008 Feb; 93(2):178-85. PubMed ID: 18223279
[TBL] [Abstract][Full Text] [Related]
15. [Long-term culture of bone marrow from patients with PH'-positive chronic myeloid leukemia].
Sadovnikova EIu; Deriugina EI; Drize NI; Udalov GA; Chertkov IL
Gematol Transfuziol; 1989 Apr; 34(4):35-9. PubMed ID: 2744379
[TBL] [Abstract][Full Text] [Related]
16. Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy.
Chen Z; Wang W; Cortes JE; Liu E; Miranda RN; Zhao C; Yuan J; Lu X; Yang W; Ameri MD; Kantarjian HM; Medeiros LJ; Hu S
Blood Cancer J; 2016 May; 6(5):e418. PubMed ID: 27152845
[No Abstract] [Full Text] [Related]
17. Chronic myeloid leukemia in accelerated phase with basophilic transformation of the bone marrow.
Cunningham MT; Ganguly S
Am J Hematol; 2006 May; 81(5):380-1. PubMed ID: 16628736
[No Abstract] [Full Text] [Related]
18. The immunohistochemical staining pattern of Gab2 correlates with distinct stages of chronic myeloid leukemia.
Aumann K; Lassmann S; Schöpflin A; May AM; Wöhrle FU; Zeiser R; Waller CF; Hauschke D; Werner M; Brummer T
Hum Pathol; 2011 May; 42(5):719-26. PubMed ID: 21292300
[TBL] [Abstract][Full Text] [Related]
19. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.
Xubo G; Xingguo L; Xianguo W; Rongzhen X; Xibin X; Lin W; Lei Z; Xiaohong Z; Genbo X; Xiaoying Z
Eur J Haematol; 2009 Oct; 83(4):292-301. PubMed ID: 19500135
[TBL] [Abstract][Full Text] [Related]
20. Fatal bone marrow aplasia during interferon-a treatment in chronic myelogenous leukemia.
Chiusolo P; Sica S; Laurenti L; Piccirillo N; Giordano G; Leone G
Haematologica; 2000 Feb; 85(2):212. PubMed ID: 10681733
[No Abstract] [Full Text] [Related]
[Next] [New Search]
